CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)-Reference-Cited by-同舟云学术

CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)

Published:2015-07-30 Issue:1 Volume:138 Page:171-181
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Balermpas Panagiotis¹²,Rödel Franz¹²,Rödel Claus¹²,Krause Mechthild³⁴⁵⁶,Linge Annett³⁴⁵,Lohaus Fabian³⁴⁵,Baumann Michael³⁴⁵⁶,Tinhofer Inge⁷⁸,Budach Volker⁷⁸,Gkika Eleni⁹¹⁰,Stuschke Martin⁹¹⁰,Avlar Melanie¹¹¹²,Grosu Anca-Lidia¹¹¹²,Abdollahi Amir¹³¹⁴,Debus Jürgen¹³¹⁴,Bayer Christine¹⁵,Stangl Stefan¹⁵,Belka Claus¹⁵¹⁶,Pigorsch Steffi¹⁵¹⁷,Multhoff Gabriele¹⁵¹⁷,Combs Stephanie E.¹⁵¹⁷,Mönnich David¹⁸¹⁹,Zips Daniel¹⁸¹⁹,Fokas Emmanouil¹²^ORCID

Affiliation:

1. German Cancer Research Center (DKFZ), Heidelberg Germany and German Cancer Consortium (DKTK); Frankfurt Germany

2. Department of Radiotherapy and Oncology; Goethe-University Frankfurt; Germany

3. German Cancer Research Center (DKFZ), Heidelberg Germany and German Cancer Consortium (DKTK); Dresden Germany

4. Department of Radiation Oncology; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden; Germany

5. OncoRay - National Center for Radiation Research in Oncology; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden; Germany

6. Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology; Germany

7. German Cancer Research Center (DKFZ), Heidelberg Germany and German Cancer Consortium (DKTK); Berlin Germany

8. Department of Radiooncology and Radiotherapy; Charité-University Hospital Berlin; Germany

9. German Cancer Research Center (DKFZ), Heidelberg Germany and German Cancer Consortium (DKTK); Essen Germany

10. Department of Radiotherapy, Medical Faculty; University of Duisburg-Essen; Essen Germany

11. German Cancer Research Center (DKFZ), Heidelberg Germany and German Cancer Consortium (DKTK); Freiburg Germany

12. Department of Radiation Oncology; University of Freiburg; Germany

13. German Cancer Research Center (DKFZ), Heidelberg Germany and German Cancer Consortium (DKTK); Heidelberg Germany

14. Department of Radiation Oncology; Heidelberg Ion Therapy Center (HIT), Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), University of Heidelberg Medical School and German Cancer Research Center (DKFZ); Germany

15. German Cancer Research Center (DKFZ), Heidelberg Germany and German Cancer Consortium (DKTK); Munich Germany

16. Department of Radiotherapy and Radiation Oncology; Ludwig-Maximilians-University; Munich Germany

17. Department of Radiation Oncology; Technical University Munich; Germany

18. German Cancer Research Center (DKFZ), Heidelberg Germany and German Cancer Consortium (DKTK); Tübingen Germany

19. Department of Radiation Oncology; Faculty of Medicine and University Hospital Tübingen, Eberhard Karls University Tübingen; Germany

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference51 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

2. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck;Cooper;N Engl J Med,2004

3. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer;Bernier;N Engl J Med,2004

4. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers;Chaturvedi;J Clin Oncol,2013

5. Human papillomavirus and rising oropharyngeal cancer incidence in the United States;Chaturvedi;J Clin Oncol,2011

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive and prognostic value of aurora kinase A combined with tumor-infiltrating lymphocytes in medullary thyroid carcinoma;2023-12-11

2. B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma;Annals of Oncology;2023-12

3. Radiotherapy-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with laryngeal cancer indicate poor prognosis;Frontiers in Oncology;2023-10-10

4. Evaluation of tumor-infiltrating T & B lymphocytes and their association and distribution in oral squamous cell carcinoma tumor microenvironment: An in vitro immunohistochemical study;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2023-08

5. Protease-Activated Receptor 1 (PAR1) Expression Contributes to HPV-Associated Oropharyngeal Cancer Prognosis;Head and Neck Pathology;2023-07-24